Panbela Therapeutics Short ratio
What is the Short ratio of Panbela Therapeutics?
The Short ratio of Panbela Therapeutics Inc. is 0.03
What is the definition of Short ratio?
Short ratio is the number of shares sold short divided by the average daily volume.
= short interest / average daily volume
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Short ratio of companies in the Health Care sector on NASDAQ compared to Panbela Therapeutics
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Companies with short ratio similar to Panbela Therapeutics
- Sustainable Real Estate Dividen has Short ratio of 0.02
- The Hempshire Inc has Short ratio of 0.02
- Leonovus has Short ratio of 0.02
- Kiboko Gold Inc has Short ratio of 0.02
- St Charles Resources Inc has Short ratio of 0.02
- 262244 has Short ratio of 0.02
- Panbela Therapeutics has Short ratio of 0.03
- Total Helium Ltd has Short ratio of 0.04
- OpenSesame Acquisition has Short ratio of 0.04
- Rackla Metals has Short ratio of 0.04
- B. Riley Principal Merger II has Short ratio of 0.04
- Millrock Resources has Short ratio of 0.04
- Mosaic Capital has Short ratio of 0.04